Uncategorised - European Medical Journal

Fast Five: Rheumatology in the Next Decade

In this Fast Five, Christine Peoples shares what she’s most excited about in rheumatology and the biggest shifts shaping patient care…

Rethinking UTIs: Interview with Florian Wagenlehner

UTIs cover a very broad area; there isn’t just one type. Therefore, we try to better classify them. Traditionally, UTIs are divided into uncomplicated and complicated infections…

Man holiday bowel cancer blue ribbon

Actor's death spotlights early-onset bowel cancer

James Van Der Beek’s death from bowel cancer has thrust rising colorectal cancer rates back into the spotlight.

breast screening

First-Time NHS Breast Screening Attendance Hits 10-Year High

The number of women attending their first NHS mammogram has hit a 10-year high, NHS data has revealed.

Wildfire Smoke PM2.5 Linked to Thousands of Deaths - EMJ

Wildfire Smoke PM2.5 Linked to Thousands of Deaths

Major study finds chronic exposure to wildfire smoke PM2.5 linked to 24,000 USA deaths per year, with no safe threshold and strong neurological impacts.

Two-Thirds of Maternal Deaths Occur in Conflict Zones - EMJ

Nearly Two-Thirds of Maternal Deaths Occur in Conflict Zones

The WHO has highlighted a surge in maternal deaths in conflict and fragile settings, where an estimated two-thirds of all maternal deaths occur.

Alcohol Use and Borderline Personality Disorder Link - EMJ

Strong Link Between Borderline Personality Disorder and Alcohol Use

Study shows alcohol use disorders affects 55% of people with borderline personality disorder, highlighting urgent need for integrated clinical care.

Inside Virus Evolution: Interview with Edward Holmes

All human viruses ultimately come from animals, and humans transmit viruses to animals too, so it’s a two-way traffic.

Atopic Dermatitis Immune Signature in Depression - EMJ

Major Depressive Disorder Shares Immune Signature with AD

Major depressive disorder shares a Th2 immune signature with atopic dermatitis, highlighting dupilumab as a potential targeted therapy.

Vision Loss Risk with Semaglutide Use - EMJ

Semaglutide Associated with Optic Neuropathy and Vision Loss

New study links semaglutide to rare optic nerve damage, highlighting the need for increased awareness, monitoring, and informed prescribing.